hAD-MSCs Ameliorated Psoriasis-Like Skin Inflammation by Inhibiting the Neutrophil Migration
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl46178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Feng Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Affiliated Hospital of Soochow University, 215004 Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Psoriasis, Mesenchymal Stem Cells, Neutrophils, Neutrophil Infiltration. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Natural Science Foundation, Suzhou Basic Research Pilot Project.
Abstract (Originalsprache)
Background
Psoriasis is a chronic inflammatory skin disease driven by an abnormal immune response. Mesenchymal stem cells have strong immunomodulatory properties. Therefore, we investigated the therapeutic effects and underlying mechanisms of human adipose-derived mesenchymal stem cells (hAD-MSCs) in a psoriasis-like mouse model.
Methods
A psoriasis-like mouse model was established and hAD-MSCs were administered via subcutaneous injection. Skin thickness was evaluated using hematoxylin and eosin (H&E) staining, and disease severity was assessed using the Psoriasis Area Severity Index (PASI). Neutrophil counts and Signal Transducer and Activator of Transcription 3 (STAT3) positive keratinocytes in the skin were evaluated by immunohistochemistry (IHC). Additionally, we evaluated the cytokine expression by quantitative PCR (q-PCR). Results: hAD-MSCs significantly attenuated psoriasis-like skin inflammation. Neutrophil infiltration was markedly reduced in psoriatic lesions following hAD-MSC treatment. We found that hAD-MSCs inhibit neutrophil recruitment by lowering CXCL1 levels in the skin, which may be linked to reduced phosphorylation of STAT3.
Conclusions
Our findings highlight the potential of hAD-MSCs as a potent therapeutic strategy for inhibiting neutrophil recruitment and ameliorating psoriasis-like inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The Second Affiliated Hospital of Soochow University, 215004 Suzhou, Jiangsu, China.
- Department of Dermatology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, 215002 Suzhou, Jiangsu, China.
- Department of Dermatology, Gongli Hospital of Shanghai Pudong New Area, 200135 Shanghai, China.
- Department of Dermatology, Jiangyin Hospital of Traditional Chinese Medicine, Jiangyin Hospital Affiliated to Nanjing University of Chinese Medicine, 214400 Jiangyin, Jiangsu, China.
Förderung
- National Natural Science Foundation of China
- Jiangsu Provincial Natural Science Foundation
- Suzhou Basic Research Pilot Project
- Suzhou Science and Technology Bureau Project
- Science and Technology Development Foundation of Nanjing Medical University
- Youth Program of the Shanghai Municipal Health Commission
Zitieren
APA
Shi, F., Zhang, L., Cheng, P., Chen, L., Mao, Q., & Ji, J. (2025). hAD-MSCs Ameliorated Psoriasis-Like Skin Inflammation by Inhibiting the Neutrophil Migration. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl46178
Vancouver
Shi F, Zhang L, Cheng P, Chen L, Mao Q, Ji J. hAD-MSCs Ameliorated Psoriasis-Like Skin Inflammation by Inhibiting the Neutrophil Migration. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl46178
BibTeX
@article{Shi2025,
author = {Shi, Feng and Zhang, Lingling and Cheng, Ping and Chen, Lingling and Mao, Qiuxia and Ji, Jiang},
title = {hAD-MSCs Ameliorated Psoriasis-Like Skin Inflammation by Inhibiting the Neutrophil Migration},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl46178}
}
EUVIMED